newsfilter
← Latest News
ACCESS Newswire·

Dermata Therapeutics Announces Closing of $2.55 Million Private Placement Priced At-The-Market Under Nasdaq Rules

SAN DIEGO, CA / ACCESS Newswire / January 23, 2025 / Dermata Therapeutics, Inc. , a late-stage biotechnology company focused on the treatment